Inhibition of mediator and cytokine release from dispersed nasal polyp cells by terfenadine |
| |
Authors: | L Crampette B Mainprice M Bloom J Bousquet A M Campbell |
| |
Institution: | Clinique des Maladies Respiratoires and CJF INSERM 92/10, Hôpital Arnaud de Villeneuve, Centre Hospitalier Universitaire, 34295-Montpellier-Cedex 5;Service d'ORL, Centre Hospitalier Universitaire, 34295-Montpellier-Cedex 5;Marion Merrell Dow SA, 130 rue Victor Hugo, 92303-Levallois-Perret-Cedex, France |
| |
Abstract: | The mechanism of action of H1-blockers requires elucidation because they may possess properties unrelated to the blockage of histamine at its receptor level. A study was performed with enzymatically dispersed cells obtained from nasal polyps to examine the effect of terfenadine (0.1–10 μmol) on the release of leukotrienes (LT) (LTC4/D4 and LTB4) after stimulation by anti-IgE, and on the spontaneous release of cytokines (granulocyte/macrophage-colony stimulating factor GM-CSF] and tumor necrosis factor-alpha TNF-α]) released from cells cultured for 6 h. Terfenadine inhibited significantly, and in a dose-dependent manner, the release of LTC4/D4, LTB4, TNF-α, and GM-CSF. IC50 values were determined for LTC4/D4 (8 μmol), LTB4 (9.9 μmol), TNF-α (6.1 μmol), and GM-CSF (4 μmol). Terfenadine was found to possess new antiallergic properties with a novel in vitro model which mimics more closely inflammatory cells of allergic rhinitis or asthma. |
| |
Keywords: | cytokine leukotriene nasal polyp terfenadine |
|
|